Synonym
Ro 24-0238; Ro 24 0238; Ro-24-0238.
IUPAC/Chemical Name
(R-(E,E))-5-(4-Methoxyphenyl)-N-(1-methyl-4-(3-pyridinyl)butyl)-2,4-decadienamide
InChi Key
HLCHRSFXEXAMLU-YDQNRGGDSA-N
InChi Code
InChI=1S/C27H36N2O2/c1-4-5-6-13-24(25-16-18-26(31-3)19-17-25)14-8-15-27(30)29-22(2)10-7-11-23-12-9-20-28-21-23/h8-9,12,14-22H,4-7,10-11,13H2,1-3H3,(H,29,30)/b15-8+,24-14+/t22-/m1/s1
SMILES Code
CCCCC/C(C1=CC=C(OC)C=C1)=C\C=C\C(N[C@H](C)CCCC2=CC=CN=C2)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
420.60
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Erickson KL, Howard AD, Hubbard NE. Induction and modulation of macrophage Ia antigen expression by platelet-activating factor. J Leukoc Biol. 1997 Dec;62(6):845-51. PubMed PMID: 9400826.
2: Negro Alvarez JM, Miralles López JC, Ortiz Martínez JL, Abellán Alemán A, Rubio del Barrio R. Platelet-activating factor antagonists. Allergol Immunopathol (Madr). 1997 Sep-Oct;25(5):249-58. Review. PubMed PMID: 9395010.
3: Abeck D, Andersson T, Grosshans E, Jablonska S, Kragballe K, Vahlquist A, Schmidt T, Dupuy P, Ring J. Topical application of a platelet-activating factor (PAF) antagonist in atopic dermatitis. Acta Derm Venereol. 1997 Nov;77(6):449-51. PubMed PMID: 9394979.
4: Elbers ME, Gerritsen MJ, van de Kerkhof PC. The effect of topical application of the platelet-activating factor-antagonist, Ro 24-0238, in psoriasis vulgaris--a clinical and immunohistochemical study. Clin Exp Dermatol. 1994 Nov;19(6):453-7. PubMed PMID: 7889665.
5: Coffen DL, Okabe M, Sun RC, Lee S, Matcham GW. Aminotransferase catalysis applied to the synthesis of a PAF antagonist. Bioorg Med Chem. 1994 Jun;2(6):411-3. PubMed PMID: 8000861.
6: Wang KA, Blain RW, Szuna AJ. Multidimensional narrow bore liquid chromatography analysis of Ro 24-0238 in human plasma. J Pharm Biomed Anal. 1994 Jan;12(1):105-10. PubMed PMID: 8161596.
7: Will PC, Thomas TK, Iverson L, Buckman D, Weis W, Wilson C, Srivastava A. Platelet activating factor as a proinflammatory mediator in acetic-induced colitis in the rat. Agents Actions. 1991 Sep;34(1-2):181-4. PubMed PMID: 1793026.
